ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.43
1.10%
Dow Jones
39,880.28
0.81%
US Dollar vs MXN
16.6872
-0.95%
Brent Oil
82.70
0.18%
Bitcoin
66,013.03
7.29%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Windtree Therapeutics Com (DSCO)

  7. Windtree Therapeutics Com (DSCO) Noticias

DSCO

Discovery labs (DSCO)

Windtree Therapeutics Com
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DSCO
FechaHoraFuenteTítuloSímboloCompañía
18/04/201615:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DSCOWindtree Therapeutics Com
18/04/201607:30PR Newswire (US)Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201616:30Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201616:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201605:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DSCOWindtree Therapeutics Com
24/03/201606:00PR Newswire (US)Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business UpdatesNASDAQ:DSCOWindtree Therapeutics Com
16/03/201616:15PR Newswire (US)Discovery Labs to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Thursday, March 24, 2016NASDAQ:DSCOWindtree Therapeutics Com
16/02/201610:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DSCOWindtree Therapeutics Com
16/02/201608:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DSCOWindtree Therapeutics Com
03/02/201617:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSCOWindtree Therapeutics Com
03/02/201615:06PR Newswire (US)Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:DSCOWindtree Therapeutics Com
02/02/201615:40Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DSCOWindtree Therapeutics Com
01/02/201615:01PR Newswire (US)Discovery Labs Announces Appointment of New Chief Executive Officer and Provides an Update on AEROSURF® Phase 2 ProgramNASDAQ:DSCOWindtree Therapeutics Com
21/01/201615:10PR Newswire (US)Discovery Labs Announces Reverse Stock SplitNASDAQ:DSCOWindtree Therapeutics Com
13/01/201616:18Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:DSCOWindtree Therapeutics Com
13/01/201615:30Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:DSCOWindtree Therapeutics Com
29/12/201515:05PR Newswire (US)Discovery Labs Announces Initiation of AEROSURF® Phase 2b Clinical TrialNASDAQ:DSCOWindtree Therapeutics Com
14/12/201516:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DSCOWindtree Therapeutics Com
10/12/201506:30PR Newswire (US)Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot...NASDAQ:DSCOWindtree Therapeutics Com
02/12/201516:20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:DSCOWindtree Therapeutics Com
12/11/201506:00PR Newswire (US)Discovery Labs Announces Top Line Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestati...NASDAQ:DSCOWindtree Therapeutics Com
06/11/201507:30PR Newswire (US)Discovery Labs to Announce Results from AEROSURF® Phase 2a Expansion Clinical TrialNASDAQ:DSCOWindtree Therapeutics Com
05/11/201515:15PR Newswire (US)Discovery Labs Provides Business Update and Reports Third Quarter 2015 Financial ResultsNASDAQ:DSCOWindtree Therapeutics Com
21/10/201506:30PR Newswire (US)Discovery Labs Announces Completion of Enrollment in AEROSURF® Phase 2a Dose Expansion TrialNASDAQ:DSCOWindtree Therapeutics Com
10/08/201516:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DSCOWindtree Therapeutics Com
10/08/201515:45PR Newswire (US)Discovery Labs Provides Business Update and Reports Second Quarter 2015 Financial ResultsNASDAQ:DSCOWindtree Therapeutics Com
03/08/201515:15PR Newswire (US)Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other ...NASDAQ:DSCOWindtree Therapeutics Com
30/07/201506:30PR Newswire (US)Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfacta...NASDAQ:DSCOWindtree Therapeutics Com
22/07/201515:15PR Newswire (US)Discovery Labs Announces Completion of $40.25 Million Public OfferingNASDAQ:DSCOWindtree Therapeutics Com
21/07/201512:39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DSCOWindtree Therapeutics Com
 Showing the most relevant articles for your search:NASDAQ:DSCO

Su Consulta Reciente

NASDAQ
HBT
HBT Financial
NYSE
SJR
Shaw Communications
LSE
WSG
Westminster
BIT
UI344C
Unicredit Bank
USOTC
SYHMD
Synthomer (PK)
BIT
UI545A
Unicredit Bank
MRTX
TTZETH
TRITZIUM
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados